Results 111 to 120 of about 8,073 (181)

Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. [PDF]

Mediterr J Hematol Infect Dis
Paciaroni K, Campagna S, Villiva N, Maffini E, Celesti F, Tordi A, Lombardi M, Dragonetti G, di Toritto TC.   +8 more
europepmc   +1 more source

Real-world evidence of imatinib treatment in younger and older patients with chronic myeloid leukaemia: A retrospective single centre analysis. [PDF]

Oncol Lett
Graf R, Kreye G, Pecherstorfer M, Singer J.   +3 more
europepmc   +1 more source

NK cell-based immunotherapy strategies for myeloid leukemia. [PDF]

Front Immunol
Zhang L, Zhao Y, Dong Y, Jiang X.
europepmc   +1 more source

Management of chronic-phase CML in later lines: a Hong Kong consensus recommendation. [PDF]

Ann Hematol
Cheung CYM, Ha CY, Kho B, Lau CK, Lau JSM, Lin SY, Mak VWM, Wong RSM, Kwong YL.   +8 more
europepmc   +1 more source

A Rare Case of Myelofibrosis Progressing to BCR-ABL1-Positive Chronic Myeloid Leukemia With Discordant Molecular Testing. [PDF]

Cureus
Badyal H, Dogra V, Dogra R, Shelke A.
europepmc   +1 more source

Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Myeloid Leukemias. [PDF]

Cureus
Alekrish Y, Alotaibi S, Iqbal Z, Aleem A.   +3 more
europepmc   +1 more source

Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry. [PDF]

Sci Rep
Suzuki K, Watanabe N, Tsukune Y, Inano T, Kinoshita S, Tomoda S, Yamada K, Konishi Y, Kuwana T, Sugiyama T, Fukada K, Yamada K, Ando M, Takaku T.   +13 more
europepmc   +1 more source

Sustained treatment-free remission in two chronic myeloid leukemia patients after asciminib discontinuation: a report of two cases. [PDF]

Ann Hematol
Yousefi A, Levin MD, Cornelissen JJ, Westerweel PE.   +3 more
europepmc   +1 more source

Targeting WEE1 and asciminib suppresses ABL-tyrosine kinase inhibitor-resistant chronic myeloid leukemia cells. [PDF]

Discov Oncol
Okabe S, Moriyama M, Gotoh A, Akahane D.
europepmc   +1 more source

Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]

Nucleic Acids Res
Sharma S, Thomas E, Dahal S, Das S, Kothari S, Roy U, Kumari N, Gopalakrishnan V, Raghavan SC.   +8 more
europepmc   +1 more source